LOINC Code 73971-4 : Methylenedioxymethamphetamine(MDMA)+Methylenedioxyethylamphetamine (MDEA)+Methylenedioxyamphetamine(MDA) [Interpretation] in Urine Qualitative

Properties

CLASS	DRUG/TOX	LP7790-1
COMPONENT	Methylenedioxymethamphetamine+Methylenedioxyethylamphetamine+Methylenedioxyamphetamine	LP172767-8
PROPERTY	Imp	LP6819-9
TIME_ASPCT	Pt	LP6960-1
SYSTEM	Urine	LP7681-2
SCALE_TYP	Ord	LP7751-3
AnswerList	Pos\|Neg	LL360-9
parent	Methylenedioxymethamphetamine(MDMA)+Methylenedioxyethylamphetamine (MDEA)+Methylenedioxyamphetamine(MDA) \| Urine \| Drug toxicology	LP407466-4
CLASSTYPE	Laboratory class
ORDER_OBS	Both
STATUS	ACTIVE

Displays

LONG_COMMON_NAME	en-US	Methylenedioxymethamphetamine(MDMA)+Methylenedioxyethylamphetamine (MDEA)+Methylenedioxyamphetamine(MDA) [Interpretation] in Urine Qualitative
LONG_COMMON_NAME	en-US	Methylenedioxymethamphetamine(MDMA)+Methylenedioxyethylamphetamine (MDEA)+Methylenedioxyamphetamine(MDA) [Interpretation] in Urine Qualitative
SHORTNAME	en-US	MDMA+MDEA+MDA Ur-Imp
ConsumerName	en-US	Methylenedioxymethamphetamine(MDMA)+Methylenedioxyethylamphetamine (MDEA)+Methylenedioxyamphetamine(MDA), Urine
LONG_COMMON_NAME	fr-FR	Méthylènedioxymethamphétamine+méthylènedioxyéthylamphétamine+Méthylènedioxyamphétamine [Interprétation] Urine ; Qualitatif
LONG_COMMON_NAME	es-MX	Metilendioximetanfetamina + Metilendioxietilanfetamina + Metilendioxianfetamina: Orina : Punto temporal: Impresión / interpretación del estudio: Ordinal:

LOINC Version: 2.81